LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...

(RTTNews) - Shares of medical technology firm AngioDynamics, Inc. (ANGO) are rising more than 8% in pre-market on Wednesday after the company said on Tuesday that the FDA granted Breakthrough Device ...

AngioDynamics (NASDAQ:ANGO) said that it has received breakthrough device designation from the FDA for its AngioVac System for the non-surgical removal of vegetation from the right heart. The ...

ALBANY, N.Y., AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announce the enrollment ...

Lush vegetation is great for a gardener, but alarming for a cardiologist. For them, the news that Angiodynamics Inc. received U.S. FDA breakthrough device designation for its Angiovac system to remove ...

AngioDynamics, a provider of minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is to acquire all the outstanding capital stock of Vortex ...

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, ...

Another mixed quarter in Q3 FY'22 for AngioDynamics, despite strengths in its international markets. Management revised guidance higher, but this may widen the operating loss as well, in my view.